Compositions of allosteric hemoglobin modifiers and methods of making the same

Details for Australian Patent Application No. 2005234796 (hide)

Owner Allos Therapeutics, Inc.

Inventors Murray, Chris; Johnson, Douglas G.; Carvalho, Alexandre J. G. G.; Etter, Jeffrey B.; Santos, Antonio M.; Quick, Al

Agent Davies Collison Cave

Pub. Number AU-A-2005234796

PCT Pub. Number WO2005/102305

Priority 60/564,721 22.04.04 US

Filing date 22 April 2005

Wipo publication date 3 November 2005

International Classifications

C07C 261/00 (2006.01) Derivatives of cyanic acid

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07C 69/76 (2006.01) Esters of carboxylic acids

C07C 229/00 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/102305 Priority application(s): WO2005/102305

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005234798-System and method for routing messages

2005234795-Use of nickel to correct growth disorders in plants